[生性肺部疾病:在差异诊断迷宫中的时间压力]
Sebastian Hahn1, Elena Heizmann1, Anne-Christin Stöwhas2
1Klinik für Pneumologie, Universitätsspital Zürich.
Praxis
|February 18, 2025
概括
本案例研究回顾了带有多炎的eosinophilic granulomatosis (EGPA),强调了诊断和管理方面的挑战. 它讨论了EGPA严重程度分类和这种罕见疾病的当前治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 带有多炎 (EGPA) 的异性粒状炎是一种罕见的全身性血管炎.
- 异性肺部疾病存在诊断和管理的复杂性.
- 了解EGPA的分类和处理是至关重要的.
研究的目的:
- 为了展示一个EGPA的案例.
- 为了审查eosinophilic肺部疾病.
- 讨论EGPA分类和当前处理.
主要方法:
- 案件呈现方式.
- 关于EGPA和eosinophilic肺部疾病的文献综述.
- 对诊断和管理策略的分析.
主要成果:
- 对EGPA的诊断和管理构成重大挑战.
- 严重程度分类有助于风险分层.
- 目前的治疗包括皮质类固醇和免疫抑制剂.
结论:
- 为了有效管理EGPA,需要采用多学科的方法.
- 及时诊断和量身定制的治疗对于改善患者的治疗结果至关重要.
- 对新型治疗策略的进一步研究是有必要的.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Pneumonia III: Complications and Assessment
146
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
173
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
173


